zPREDICTA
The AI engine Fit Assessment
BetaThe company develops pharma-focused technology for automated drug development, including a bio-simulation platform and 3D organ-specific models to predict patient drug responses, aligning with the central pharma tech requirement.
Blurb
HQ Location
Founded
Employees
Total funding raised
Funding Status
zPREDICTA’s bio-simulation technology combines biology with automation and computation to automate drug development. zPREDICTA's bio-simulation platform enables pharma to rapidly identify drug candidates that will be effective in patients.
r-Organ is a set of next generation 3D culture models that provide 1-to-1 reconstruction of human tissue microenvironment in an organ- and disease-specific manner allowing accurate prediction of drug response. Utilizing r-Organ technology, zPREDICTA is mapping cellular behavior in response to anticancer drugs.